Novo Nordisk A/S (NYSE:NVO)

54.77
Delayed Data
As of Apr 17
 -0.20 / -0.36%
Today’s Change
41.72
Today|||52-Week Range
56.18
+29.42%
Year-to-Date

Today’s Trading

Previous close54.97
Today’s open54.61
Day’s range54.25 - 54.78
Volume964,014
Average volume (3 months)1,725,980
Market cap$112.8B
Dividend yield1.39%
Data as of 4:03pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+14.80%
Revenue growth (last year)+5.60%
P/E ratio5.4
Price/Sales7.05
Price/Book21.77

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.29-0.61%
BMYBristol-Myers Squibb+1.67+2.62%
ACTActavis+0.60+0.20%
ABBVAbbVie-0.30-0.48%
Data as of 4:07pm ET, 04/17/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.51
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Bagsvrd, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers